Möchten Sie immer auf dem neuesten Stand bleiben?

Synendos Therapeutics Starts Phase 2 Trial in Generalized Anxiety Disorder, marking the first time a SERI molecule is dosed in a patient population

The presentation for the first quarter 2026 results is available on the company’s website. The Group's CEO Bjørn Hembre and CFO Robert Robertsson will be presenting the Group's first quarter results...

Lochem, 20 May 2026 Start and update of share buy-back programme ForFarmers  ForFarmers N.V. (ForFarmers) has repurchased 82,377 shares in the period from 13 May 2026 through 19 May 2026. The...

Lochem, 20 mei 2026 Start en voortgang inkoopprogramma eigen aandelen ForFarmers  ForFarmers N.V. (ForFarmers) heeft 82.377 aandelen ingekocht in de periode van 13 mei 2026 tot en met 19 mei...

NEW YORK, May 20, 2026 (GLOBE NEWSWIRE) -- Moburst, the global leader in digital marketing and AI-powered solutions, today announces a strategic $11.8 million investment from Chrysalis Holdings,...

HONG KONG, May 20, 2026 (GLOBE NEWSWIRE) -- CoinEx Charity announced its partnership with the ONG Bitcoin Argentina to support the education universities and new technologies in Argentina.  More...

FLYR powers Riyadh Air's launch as the world's first full-service airline built on a native Offer & Order platform.

* Issuer: Subsea 7 S.A. * Ex. date: 20 May 2026 * Dividend amount: NOK 13.00 * Announced currency: Norwegian Krone Contact for investment community enquiries: Katherine Tonks Director, Investor...

Louvain-la-Neuve, Belgium, May 20, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and electron beam and X-ray solutions for industrial advanced...

Louvain-la-Neuve, Belgique, le 20 mai 2026 – IBA (Ion Beam Applications S.A., EURONEXT), leader mondial des technologies d’accélérateurs de particules et des solutions de faisceaux d’électrons et à...